|
2024
|
Invention
|
Lysates of recombinant yeast for inducing cellular immune responses.
Disclosed are immunogenic p... |
|
|
Invention
|
Combination immunotherapy compositions against cancer and methods.
Disclosed are immunotherapeut... |
|
2023
|
Invention
|
Combination immunotherapy compositions against cancer and methods. Disclosed are immunotherapeuti... |
|
2021
|
Invention
|
Anti covid-19 therapies using nucleocapsid and spike proteins.
Compositions and methods are pres... |
|
2020
|
Invention
|
Yeast-brachyury immunotherapeutic compositions. Disclosed are yeast-based immunotherapeutic compo... |
|
2019
|
Invention
|
Yeast-based immunotherapy for chordoma.
Disclosed are methods of the treatment or prevention of ... |
|
|
Invention
|
Methods and compositions for modulating myeloid-derived suppressor cells.
The present invention ... |
|
|
Invention
|
Methods and compositions for modulating myeloid-derived suppressor cells. The present invention i... |
|
|
Invention
|
Lysates of recombinant yeast for inducing cellular immune responses. Disclosed are immunogenic ph... |
|
|
Invention
|
Lysates of recombinant yeast for inducing cellular immune responses. Disclosed are methods of mak... |
|
|
Invention
|
Compositions and methods for the treatment or prevention of human immunodeficiency virus infectio... |
|
|
Invention
|
Compositions and methods for the treatment or prevention of tuberculosis. Disclosed are yeast-bas... |
|
2018
|
Invention
|
Yeast-muc1 immunotherapeutic compositions and uses thereof. Disclosed are yeast-based immunothera... |
|
|
Invention
|
Compositions and methods for the treatment or prevention of hepatitis b virus infection. Disclose... |
|
2017
|
Invention
|
Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immun... |
|
|
Invention
|
Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus inf... |
|
2016
|
Invention
|
Modified yeast-brachyury immunotherapeutic compositions. Disclosed are improved yeast-based immun... |
|
2015
|
Invention
|
Yeast-based immunotherapy and type i interferon sensitivity. Disclosed are methods of treating in... |
|
|
Invention
|
Ras g12r immunotherapy for ras mutation-positive cancers. Disclosed are Ras G12R antigens in immu... |
|
2014
|
Invention
|
Yeast-based therapeutic for chronic hepatitis b infection. Disclosed are yeast-based immunotherap... |
|
|
Invention
|
Yeast-based immunotherapy for chordoma. One embodiment of the invention relates to a method to tr... |
|
|
Invention
|
Yeast-based vaccines as immunotherapy.
Compositions and methods for treating and/or preventing a... |
|
2013
|
Invention
|
Compositions and methods for eliciting an immune response to escape mutants of targeted therapies... |
|
2012
|
G/S
|
[ Immunotherapy products, namely, pharmaceutical preparations for treatment of cancer and infecti... |
|
2011
|
Invention
|
Compositions and methods for the treatment or prevention of human adenovirus-36 infection. Disclo... |
|
2008
|
G/S
|
IMMUNOTHERAPY PRODUCTS, NAMELY, PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER AND INFECTIOU... |
|
2005
|
G/S
|
Immunotherapy products, namely pharmaceutical preparations for treatment of cancer and infectious... |
|
2004
|
G/S
|
THERAPEUTIC AND PROPHALACTIC VACCINES; PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER AND IN... |
|
|
G/S
|
PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER AND INFECTIOUS DISEASE; THERAPEUTIC AND PROPH... |
